31.05.2008 Interim Phase 2 Results of Open-Label Clinical Trial of Denosumab in Giant Cell Tumor of Bone Demonstrated 87 Percent Response Rate

31.05.2008 Early Data from Apoptosis, Angiogenesis and Growth Regulation Programs Suggest Biologic Activity in a Range of Tumor Types

31.05.2008 Amgen Presents New Data at ASCO on Four Investigational Molecules from Oncology Pipeline

31.05.2008 Amgen Reports Positive Data at ASCO from Three Studies of Denosumab in Cancer Patients

31.05.2008 Second Phase III Study of Avastin Plus Chemotherapy Shows Improved Progression-Free Survival in Women With Advanced HER2-Negative Breast Cancer

27.05.2008 Cell Therapeutics, Inc. (CTI) Announces Presentations at American Society of Clinical Oncology (ASCO) Annual Meeting

19.05.2008 Denosumab Osteoporosis Study Meets Primary and All Secondary Bone Mineral Density Endpoints in Alendronate (FOSAMAX(R)) Transition Study

15.05.2008 Amgen Highlights Data to Be Presented at ASCO

15.05.2008 Overview Provided for Studies to be Presented at the 2008 American Society of Clinical Oncology Annual Meeting; and Updated Timing Provided for Ongoing Study in Early-Stage Colon Cancer

15.05.2008 Genentech Provides Update On Studies Of Investigational Biooncology Agents To Be Presented At The American Society Of Clinical Oncology Meeting

08.05.2008 Zevalin Revenues Lead Cell Therapeutics, Inc.'s First Quarter 2008 Financial Results

07.05.2008 Amgen Announces Voting Results of Annual Meeting of Stockholders

06.05.2008 Amgen to Participate in CHMP Oncology Scientific Advisory Group Meeting in May

05.05.2008 ACADIA Pharmaceuticals Reports First Quarter 2008 Financial Results

05.05.2008 ACADIA Pharmaceuticals Announces Election of Laura A. Brege to Board of Directors

05.05.2008 European Regulatory Agency Supports OPAXIO(TM) Brand Name for Cell Therapeutics' Lung Cancer Drug